Japan Post Holdings, an Aflac 10% owner, sells $1.76m in stock By Investing.com
MPM BioVentures 2018, L.P., a 10% owner and director of Entrada Therapeutics, Inc. (), recently sold shares of the company’s common stock totaling $461,545. The transactions occurred over three days, from August 24 to August 26, 2026, with prices ranging
